Efficient transduction of murine B lymphocytes and B lymphoma lines by modified adenoviral vectors: enhancement via targeting to FcR and heparan-containing proteins-Reference-Cited by-同舟云学术

Efficient transduction of murine B lymphocytes and B lymphoma lines by modified adenoviral vectors: enhancement via targeting to FcR and heparan-containing proteins

Published:2001-06 Issue:12 Volume:8 Page:938-945
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Li L,Wickham TJ,Keegan AD

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301487.pdf

Reference34 articles.

1. Ouyang W et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism Immunity 1998 9: 745–755

2. Huang, H, Panettier C, Hu-Li J, Paul WE . Transient transfection of primary helper T cells by particle-mediated gene transfer J Immunol Meth 1998 215: 173–177

3. Cantwell MJ, Sharma S, Friedman T, Kipps TJ . Adenovirus vector infection of chronic lympocytic leukemia B cells Blood 1996 88: 4676–4683

4. Gonzalez RR et al. Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells Hum Gene Ther 1999 10: 2709–2717

5. Leon RP et al. Adenoviral-mediated gene transfer in lymphocytes Proc Natl Acad Sci USA 1998 95: 13159–13164

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vector Strategies to Actualize B Cell–Based Gene Therapies;The Journal of Immunology;2021-07-28

2. A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity;eLife;2019-11-19

3. Physically crosslinked injectable hydrogels for long-term delivery of oncolytic adenoviruses for cancer treatment;Biomaterials Science;2019

4. A curative combination therapy for lymphomas achieves high fractional cell killing through low cross-resistance and drug additivity but not synergy;2018-11-05

5. Drugs in a Curative Combination Therapy for Lymphoma Exhibit Low Cross-Resistance But Not Pharmacological Synergy;SSRN Electronic Journal;2018